Nicola Carella
Bari, 70013, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
RETRACTED: Refolo et al. Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma Cells. Int. J. Mol. Sci. 2018, 19, 1518.
Journal: International journal of molecular sciences
Published: February 09, 2026
Insights into the GALAD score: A new optimal cut-off for hepatocellular carcinoma.
Journal: World journal of gastroenterology
Published: July 08, 2025
Healthy Lifestyle Changes Improve Cortisol Levels and Liver Steatosis in MASLD Patients: Results from a Randomized Clinical Trial.
Journal: Nutrients
Published: November 14, 2024
Role of gastroenterologists and healthcare providers in promoting COVID-19 immunization among individuals with inflammatory bowel disease: A systematic review and meta-analysis on a global scale.
Journal: Human vaccines & immunotherapeutics
Published: May 16, 2024
Exosome Released FZD10 Increases Ki-67 Expression via Phospho-ERK1/2 in Colorectal and Gastric Cancer.
Journal: Frontiers in oncology
Published: June 24, 2021
RETRACTED: Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma Cells.
Journal: International journal of molecular sciences
Published: April 20, 2018
Strong enhancement by IGF1-R antagonists of hepatocellular carcinoma cell migration inhibition by Sorafenib and/or vitamin K1.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: January 18, 2018
Last Updated: 09/26/2026